title: Pharmacogenomics testing for type B adverse drug reactions to anti-infective drugs: the example of hypersensitivity to abacavir.
authors.affiliation: Department of Pharmacology, University of Extremadura, Avda de la Universidad s/n, E-10071 Caceres, Spain. jagundez@unex.es.
authors.forename: Jose A G
authors.initials: JA
authors.lastname: Agundez
authors.forename: Gara
authors.initials: G
authors.lastname: Esguevillas
authors.forename: Gemma
authors.initials: G
authors.lastname: Amo
authors.forename: Elena
authors.initials: E
authors.lastname: Garcia-Martin
mesh_terms: D015224:Dideoxynucleosides / Q000009:adverse effects*; D004342:Drug Hypersensitivity / Q000175:diagnosis / Q000209:etiology / Q000235:genetics*; D020022:Genetic Predisposition to Disease; D015235:HLA-B Antigens / Q000235:genetics*; D006801:Humans; D010597:Pharmacogenetics; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D018570:Risk Assessment; D000099227:Abacavir
chemical_list: D015224:Dideoxynucleosides; D015235:HLA-B Antigens; D018894:Reverse Transcriptase Inhibitors; D000099227:Abacavir; C484830:HLA-B*57:01 antigen